PITX2 as a Sensitive and Specific Marker of Midgut Neuroendocrine Tumors: Results from a Cohort of 1157 Primary Neuroendocrine Neoplasms

被引:3
|
作者
Grass, Albert [1 ,2 ]
Kasajima, Atsuko [3 ]
Foersch, Sebastian [4 ]
Kriegsmann, Mark [5 ]
Brobeil, Alexander [5 ]
Schmitt, Maxime [1 ,2 ]
Wagner, Daniel [4 ]
Poppinga, Jelte [2 ,6 ]
Wiese, Dominik [2 ,6 ]
Maurer, Elisabeth [2 ,6 ]
Kirschbaum, Andreas [2 ,6 ]
Muley, Thomas [7 ,8 ]
Winter, Hauke [7 ,8 ,9 ]
Rinke, Anja [2 ,10 ]
Gress, Thomas M. [2 ,10 ]
Kremer, Markus [11 ]
Evert, Matthias [12 ]
Maerkl, Bruno [13 ]
Quaas, Alexander [14 ]
Eckstein, Markus [15 ]
Tschurtschenthaler, Markus [16 ]
Kloeppel, Guenter [3 ]
Denkert, Carsten [1 ,2 ]
Bartsch, Detlef K. [2 ,6 ]
Jesinghaus, Moritz [1 ,2 ]
机构
[1] Phillips Univ Marburg, Dept Pathol, Marburg, Germany
[2] Univ Hosp Marburg, Marburg, Germany
[3] Tech Univ Munich, Dept Pathol, Munich, Germany
[4] Univ Hosp Mainz, Dept Pathol, Mainz, Germany
[5] Univ Hosp Heidelberg, Dept Pathol, Heidelberg, Germany
[6] Phillips Univ Marburg, Dept Surg, Marburg, Germany
[7] Translat Lung Res Ctr Heidelberg TLRC H, Heidelberg, Germany
[8] Heidelberg Univ Hosp, Translat Res Unit, Thoraxklin, Heidelberg, Germany
[9] Heidelberg Univ Hosp, Dept Thorac Surg, Thoraxklin, Heidelberg, Germany
[10] Phillips Univ Marburg, Dept Gastroenterol Endocrinol & Infect Dis, Marburg, Germany
[11] Stadt Klinikum Munchen, Inst Pathol, Munich, Germany
[12] Univ Hosp Regensburg, Dept Pathol, Regensburg, Germany
[13] Univ Hosp Augsburg, Inst Pathol, Augsburg, Germany
[14] Univ Hosp Cologne, Inst Pathol, Cologne, Germany
[15] Friedrich Alexander Univ Erlangen Nurnberg, Dept Pathol, Univ Hosp Erlangen, Erlangen, Germany
[16] German Canc Consortium DKTK, Inst Translat Canc Res, Partner Site Munich, Munich, Germany
关键词
midgut; neuroendocrine carcinoma; neuroendocrine neoplasms; neuroendocrine tumor; Pituitary Homeobox 2; CLASSIFICATION; CARCINOIDS; CDX-2; TTF-1; IRS;
D O I
10.1016/j.modpat.2024.100442
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
As neuroendocrine tumors (NETs) often present as metastatic lesions, immunohistochemical assignment to a site of origin is one of the most important tasks in their pathologic assessment. Because a fraction of NETs eludes the typical expression profiles of their primary localization, additional sensitive and specific markers are required to improve diagnostic certainty. We investigated the expression of the transcription factor Pituitary Homeobox 2 (PITX2) in a large-scale cohort of 909 NET and 248 neuroendocrine carcinomas (NEC) according to the immunoreactive score (IRS) and correlated PITX2 expression groups with general tumor groups and primary localization. PITX2 expression (all expression groups) was highly sensitive (98.1%) for midgut-derived NET, but not perfectly specific, as non-midgut NET (especially pulmonary/duodenal) were quite frequently weak or moderately positive. The specificity rose to 99.5% for a midgut origin of NET if only a strong PITX2 expression was considered, which was found in only 0.5% (one pancreatic/one pulmonary) of non-midgut NET. In metastases of midgut-derived NET, PITX2 was expressed in all cases (87.5% strong, 12.5% moderate), whereas CDX2 was negative or only weakly expressed in 31.3% of the metastases. In NEC, a fraction of cases (14%) showed a weak or moderate PITX2 expression, which was not associated with a specific tumor localization. Our study independently validates PITX2 as a very sensitive and specific immunohistochemical marker of midgut-derived NET in a very large collective of neuroendocrine neoplasms. Therefore, our data argue toward implementation into diagnostic panels applied for NET as a firstline midgut marker. (c) 2024 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology. This is an open access article under the CC BY -NC -ND license (http://creativecommons. org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Pitx2 is a useful marker of midgut-derived neuroendocrine tumours - an immunohistochemical study of 224 cases
    Soukup, Jiri
    Manethova, Monika
    Faistova, Hana
    Krbal, Lukas
    Vitovcova, Barbora
    Hornychova, Helena
    Drugda, Jan
    Cesak, Tomas
    Netuka, David
    Gabalec, Filip
    Ryska, Ales
    HISTOPATHOLOGY, 2022, 81 (06) : 799 - 807
  • [2] Cadherin 17 Is a Sensitive Marker of Midgut and Hindgut Neuroendocrine Tumors
    Snow, A. N.
    Mangray, S.
    Clubwala, R.
    Li, J.
    Monahan, R.
    Resnick, M.
    Yakirevich, E.
    LABORATORY INVESTIGATION, 2014, 94 : 160A - 160A
  • [3] Cadherin 17 Is a Sensitive Marker of Midgut and Hindgut Neuroendocrine Tumors
    Snow, A. N.
    Mangray, S.
    Clubwala, R.
    Li, J.
    Monahan, R.
    Resnick, M.
    Yakirevich, E.
    MODERN PATHOLOGY, 2014, 27 : 160A - 160A
  • [4] Immunoreactivity of HOXB13 in Neuroendocrine Neoplasms Is a Sensitive and Specific Marker of Rectal Well-Differentiated Neuroendocrine Tumors
    Jiri Soukup
    Monika Manethova
    Vaclav Stejskal
    Helena Hornychova
    Tomas Cesak
    David Netuka
    Ales Ryska
    Filip Gabalec
    Endocrine Pathology, 2023, 34 : 333 - 341
  • [5] Immunoreactivity of HOXB13 in Neuroendocrine Neoplasms Is a Sensitive and Specific Marker of Rectal Well-Differentiated Neuroendocrine Tumors
    Soukup, Jiri
    Manethova, Monika
    Stejskal, Vaclav
    Hornychova, Helena
    Cesak, Tomas
    Netuka, David
    Ryska, Ales
    Gabalec, Filip
    ENDOCRINE PATHOLOGY, 2023, 34 (03) : 333 - 341
  • [6] Claudin-18 is a Sensitive and a Specific Marker for Gastric Neuroendocrine Tumors
    Wong, Mary
    Huynh, Carissa
    Kim, Stacey
    Dhall, Deepti
    Guindi, Maha
    Larson, Brent
    De Peralta-Venturina, Mariza
    Balzer, Bonnie
    Waters, Kevin
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 802 - 802
  • [7] Claudin-18 Is a Sensitive and a Specific Marker for Gastric Neuroendocrine Tumors
    Wong, M.
    Huynh, C.
    Kim, S.
    Dhall, D.
    Guindi, M.
    Larson, B.
    De Peralta-Venturina, M.
    Balzer, B.
    Waters, K.
    NEUROENDOCRINOLOGY, 2020, 110 : 129 - 129
  • [8] Claudin-18 is a Sensitive and a Specific Marker for Gastric Neuroendocrine Tumors
    Wong, Mary
    Huynh, Carissa
    Kim, Stacey
    Dhall, Deepti
    Guindi, Maha
    Larson, Brent
    De Peralta-Venturina, Mariza
    Balzer, Bonnie
    Waters, Kevin
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 802 - 802
  • [9] GAD2 is a highly specific marker for neuroendocrine neoplasms of the pancreas
    Lennartz, M.
    Duennebier, N. B.
    Blessin, N. C.
    Hoeflmayer, D.
    Dwertmann Rico, S.
    Kind, S.
    Buescheck, F.
    Sauter, G.
    Simon, R.
    Minner, S.
    Bernreuther, C.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 : S39 - S39
  • [10] GAD2 Is a Highly Specific Marker for Neuroendocrine Neoplasms of the Pancreas
    Lennartz, Maximilian
    Benjamin Duennebier, Nick
    Hoeflmayer, Doris
    Dwertmann Rico, Sebastian
    Kind, Simon
    Reiswich, Viktor
    Viehweger, Florian
    Lutz, Florian
    Fraune, Christoph
    Gorbokon, Natalia
    Luebke, Andreas M.
    Hube-Magg, Claudia
    Buescheck, Franziska
    Menz, Anne
    Uhlig, Ria
    Krech, Till
    Hinsch, Andrea
    Burandt, Eike
    Sauter, Guido
    Simon, Ronald
    Kluth, Martina
    Steurer, Stefan
    Marx, Andreas H.
    Lebok, Patrick
    Dum, David
    Minner, Sarah
    Jacobsen, Frank
    Clauditz, Till S.
    Bernreuther, Christian
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2024, 48 (04) : 377 - 386